Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial
- 1 June 2018
- journal article
- research article
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 27 (6) , 1673-1682
Abstract
No abstract availableKeywords
Funding Information
- Bayer AG
- Janssen Research and Development
This publication has 15 references indexed in Scilit:
- Comparison of Functional Outcome and Stroke Recurrence in Patients with Embolic Stroke of Undetermined Source (ESUS) vs. Cardioembolic Stroke PatientsPLOS ONE, 2016
- The A-S-C-O classification identifies cardioembolic phenotypes in a high proportion of embolic stroke of undetermined source (ESUS)Journal of the Neurological Sciences, 2016
- Embolic strokes of undetermined source: Prevalence and patient features in the ESUS Global RegistryInternational Journal of Stroke, 2016
- Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based studyThe Lancet Neurology, 2015
- Embolic strokes of undetermined source: the case for a new clinical constructThe Lancet Neurology, 2014
- An Updated Definition of Stroke for the 21st CenturyStroke, 2013
- Statistics in Medicine — Reporting of Subgroup Analyses in Clinical TrialsNew England Journal of Medicine, 2007
- Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patientsJournal of Thrombosis and Haemostasis, 2005
- Subgroup analysis in randomised controlled trials: importance, indications, and interpretationThe Lancet, 2005
- Infarcts of undetermined cause: The NINCDS stroke data bankAnnals of Neurology, 1989